KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Rigel Pharmaceuticals (RIGL) over the last 11 years, with Q3 2025 value amounting to $6.0 million.

  • Rigel Pharmaceuticals' Change in Receivables rose 26014.36% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 11838.1%. This contributed to the annual value of $11.1 million for FY2024, which is 21325.49% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Change in Receivables stood at $6.0 million, which was up 26014.36% from -$1.6 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Receivables ranged from a high of $126.2 million in Q1 2021 and a low of -$124.8 million during Q2 2021
  • In the last 5 years, Rigel Pharmaceuticals' Change in Receivables had a median value of $481000.0 in 2021 and averaged $1.6 million.
  • Within the past 5 years, the most significant YoY rise in Rigel Pharmaceuticals' Change in Receivables was 2808713.97% (2021), while the steepest drop was 613884.86% (2021).
  • Rigel Pharmaceuticals' Change in Receivables (Quarter) stood at $481000.0 in 2021, then skyrocketed by 5054.89% to $24.8 million in 2022, then crashed by 71.75% to $7.0 million in 2023, then skyrocketed by 57.62% to $11.0 million in 2024, then tumbled by 45.49% to $6.0 million in 2025.
  • Its Change in Receivables was $6.0 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$68000.0 in Q1 2025.